The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Anusol HC Suppositories



SOFIBELPA22647/002/002

Main Information

Trade NameAnusol HC Suppositories
Active SubstancesHYDROCORTISONE ACETATE
Benzyl benzoate
Bismuth oxide
Balsam peru
Zinc oxide
Bismuth subgallate
Dosage FormSuppository
Licence HolderSOFIBEL
Licence NumberPA22647/002/002

Group Information

ATC CodeC05AA Corticosteroids
C05AA01 hydrocortisone

Status

License statusAuthorised
Licence Issued30/03/1990
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceProduct not subject to prescription and supply through pharmacies only subject to the following restriction: maximum pack size - 12 suppositories Pack sizes in excess of 12 suppositories are subject to medical prescription.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back